InsidersTradesSigma
Follow the 플라즈맵 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 플라즈맵 has published 6 insider filings. Market capitalisation: €16.2bn. The latest transaction was disclosed on 19 June 2026 (Other). Among the most active insiders: 드림텍. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Plasmapp is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It specializes in developing innovative solutions for medical treatment.